Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 14:30 ET | Source: Cosmos Health Inc.

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health lands follow-up order for 80K Sky Premium Life units in UAE after initial 130K sell-out, supporting 5-year goal of 3M+ units.
May 06, 2025 13:40 ET | Source: Cosmos Health Inc.

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health is eligible for an additional 180 calendar day period to regain compliance with the Nasdaq’s minimum bid price requirement.
April 30, 2025 12:50 ET | Source: Cosmos Health Inc.

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Greg Siokas has increased his stake in the Company by acquiring 1,466,764 common shares for $526,000.
April 16, 2025 12:45 ET | Source: Cosmos Health Inc.

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

FY 2024 performance was marked by revenue growth, an increase in R&D investments, and a substantial reduction in operating expenses.
April 09, 2025 13:40 ET | Source: Cosmos Health Inc.

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Cosmos Health continues upgrading its Cana facility and signs a contract with Pharmex to produce 300K bottles of the antiseptic drug AMBITASOL 1L.
April 08, 2025 10:45 ET | Source: Cosmos Health Inc.

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Cosmos Health launches Sky Premium Life in Albania with Pharma Cell as distributor and secures an initial annual order valued at $300,000.